Spongy degeneration of the brain, canavan disease

Reuben Matalon, K. Michals, R. Kaul, M. Mafee

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Spongy degeneration of the brain, Canavan disease, is an autosomal recessive leukodystrophy frequently found amongst Ashkenazi Jewish people. Excessive amounts of N-acetylaspartic acid in urine and other body fluids and deficiency of the enzyme aspartoacylase are the newly discovered biochemical markers for this disease. It is now possible to make the diagnosis of Canavan disease with certainty without the need for brain biopsy. This new information also allows for carrier testing and prenatal diagnosis. The purification of aspartoacylase will lead to the isolation of the gene for this enzyme, allowing for the use of molecular biology techniques as another tool for the diagnosis of Canavan disease.

Original languageEnglish (US)
Pages (from-to)121-124
Number of pages4
JournalInternational Pediatrics
Volume5
Issue number2
StatePublished - 1990
Externally publishedYes

Fingerprint

Canavan Disease
Brain Diseases
Body Fluids
Enzymes
Prenatal Diagnosis
Molecular Biology
Biomarkers
Urine
Biopsy
Brain
Genes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Matalon, R., Michals, K., Kaul, R., & Mafee, M. (1990). Spongy degeneration of the brain, canavan disease. International Pediatrics, 5(2), 121-124.

Spongy degeneration of the brain, canavan disease. / Matalon, Reuben; Michals, K.; Kaul, R.; Mafee, M.

In: International Pediatrics, Vol. 5, No. 2, 1990, p. 121-124.

Research output: Contribution to journalArticle

Matalon, R, Michals, K, Kaul, R & Mafee, M 1990, 'Spongy degeneration of the brain, canavan disease', International Pediatrics, vol. 5, no. 2, pp. 121-124.
Matalon, Reuben ; Michals, K. ; Kaul, R. ; Mafee, M. / Spongy degeneration of the brain, canavan disease. In: International Pediatrics. 1990 ; Vol. 5, No. 2. pp. 121-124.
@article{c775cb954cc5498fa9d486b9d97364ad,
title = "Spongy degeneration of the brain, canavan disease",
abstract = "Spongy degeneration of the brain, Canavan disease, is an autosomal recessive leukodystrophy frequently found amongst Ashkenazi Jewish people. Excessive amounts of N-acetylaspartic acid in urine and other body fluids and deficiency of the enzyme aspartoacylase are the newly discovered biochemical markers for this disease. It is now possible to make the diagnosis of Canavan disease with certainty without the need for brain biopsy. This new information also allows for carrier testing and prenatal diagnosis. The purification of aspartoacylase will lead to the isolation of the gene for this enzyme, allowing for the use of molecular biology techniques as another tool for the diagnosis of Canavan disease.",
author = "Reuben Matalon and K. Michals and R. Kaul and M. Mafee",
year = "1990",
language = "English (US)",
volume = "5",
pages = "121--124",
journal = "International Pediatrics",
issn = "0885-6265",
publisher = "Miami Children's Hospital Medical Journal Inc.",
number = "2",

}

TY - JOUR

T1 - Spongy degeneration of the brain, canavan disease

AU - Matalon, Reuben

AU - Michals, K.

AU - Kaul, R.

AU - Mafee, M.

PY - 1990

Y1 - 1990

N2 - Spongy degeneration of the brain, Canavan disease, is an autosomal recessive leukodystrophy frequently found amongst Ashkenazi Jewish people. Excessive amounts of N-acetylaspartic acid in urine and other body fluids and deficiency of the enzyme aspartoacylase are the newly discovered biochemical markers for this disease. It is now possible to make the diagnosis of Canavan disease with certainty without the need for brain biopsy. This new information also allows for carrier testing and prenatal diagnosis. The purification of aspartoacylase will lead to the isolation of the gene for this enzyme, allowing for the use of molecular biology techniques as another tool for the diagnosis of Canavan disease.

AB - Spongy degeneration of the brain, Canavan disease, is an autosomal recessive leukodystrophy frequently found amongst Ashkenazi Jewish people. Excessive amounts of N-acetylaspartic acid in urine and other body fluids and deficiency of the enzyme aspartoacylase are the newly discovered biochemical markers for this disease. It is now possible to make the diagnosis of Canavan disease with certainty without the need for brain biopsy. This new information also allows for carrier testing and prenatal diagnosis. The purification of aspartoacylase will lead to the isolation of the gene for this enzyme, allowing for the use of molecular biology techniques as another tool for the diagnosis of Canavan disease.

UR - http://www.scopus.com/inward/record.url?scp=0025552740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025552740&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 121

EP - 124

JO - International Pediatrics

JF - International Pediatrics

SN - 0885-6265

IS - 2

ER -